Mackenzie Financial’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-49,283
| Closed | -$337K | – | 1527 |
|
|
2023
Q1 | $337K | Sell |
49,283
-25,800
| -34% | -$176K | ﹤0.01% | 1148 |
|
|
2022
Q4 | $595K | Buy |
75,083
+27,393
| +57% | +$217K | ﹤0.01% | 875 |
|
|
2022
Q3 | $458K | Sell |
47,690
-8
| -0% | -$77 | ﹤0.01% | 957 |
|
|
2022
Q2 | $345K | Buy |
47,698
+14,027
| +42% | +$101K | ﹤0.01% | 1038 |
|
|
2022
Q1 | $435K | Buy |
33,671
+1,509
| +5% | +$19.5K | ﹤0.01% | 1021 |
|
|
2021
Q4 | $513K | Buy |
+32,162
| New | +$513K | ﹤0.01% | 999 |
|